- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.40 Å
- Oligo State
- hetero-1-1-mer
- Ligands
- 2 x GLC- GLC: alpha-D-glucopyranose-(1-4)-alpha-D-glucopyranose(Non-covalent)
- 3 x TRD: TRIDECANE(Non-covalent)
- 1 x MG: MAGNESIUM ION(Non-covalent)
- 1 x CA: CALCIUM ION(Non-covalent)
- 3 x CU: COPPER (II) ION(Non-covalent)
CU.6: 3 residues within 4Å:- Chain A: H.268, H.317, H.318
4 PLIP interactions:3 interactions with chain A, 1 Ligand-Water interactions- Metal complexes: A:H.268, A:H.317, A:H.318, H2O.2
CU.13: 5 residues within 4Å:- Chain B: H.189, C.224, C.228, M.235
- Ligands: CU.14
3 PLIP interactions:3 interactions with chain B- Metal complexes: B:H.189, B:C.224, B:C.228
CU.14: 5 residues within 4Å:- Chain B: C.224, E.226, C.228, H.232
- Ligands: CU.13
4 PLIP interactions:4 interactions with chain B- Metal complexes: B:C.224, B:E.226, B:C.228, B:H.232
- 2 x HEA: HEME-A(Non-covalent)
HEA.7: 33 residues within 4Å:- Chain A: G.22, V.29, T.32, M.35, R.36, W.79, I.83, H.86, M.90, M.91, V.94, V.95, A.98, G.155, W.156, Y.398, F.404, H.405, M.408, S.409, V.413, I.416, I.420, M.444, T.451, F.452, Q.455, R.465, R.466, Y.467, A.485, S.488, F.492
32 PLIP interactions:32 interactions with chain A,- Hydrophobic interactions: A:V.29, A:V.29, A:T.32, A:I.83, A:M.90, A:V.95, A:A.98, A:F.404, A:M.408, A:V.413, A:V.413, A:I.416, A:I.420, A:T.451, A:F.452, A:A.485, A:F.492, A:F.492
- Hydrogen bonds: A:T.32, A:R.36, A:W.156, A:Y.398, A:Q.455, A:R.466, A:Y.467
- Water bridges: A:R.465
- Salt bridges: A:R.465, A:R.466
- pi-Stacking: A:H.405, A:F.452
- Metal complexes: A:H.86, A:H.405
HEA.8: 30 residues within 4Å:- Chain A: W.156, W.264, V.271, Y.272, V.275, H.317, H.318, T.336, I.339, A.340, T.343, G.344, I.347, F.375, T.376, G.379, G.382, I.383, L.385, S.386, D.391, H.395, V.400, H.403, F.404, V.407, M.408, R.465
- Chain B: I.40, P.80
31 PLIP interactions:27 interactions with chain A, 3 interactions with chain B, 1 Ligand-Water interactions,- Hydrophobic interactions: A:W.264, A:V.271, A:V.275, A:T.336, A:A.340, A:T.343, A:I.347, A:F.375, A:I.383, A:L.385, A:F.404, A:F.404, A:V.407, B:I.40, B:I.40, B:P.80
- Hydrogen bonds: A:W.156, A:Y.272
- Water bridges: A:D.396, A:D.396, A:R.465, A:R.465, A:R.466
- Salt bridges: A:H.395, A:R.465, A:R.466
- pi-Cation interactions: A:H.268, A:H.268, A:H.403
- Metal complexes: A:H.403, H2O.2
- 1 x DMU: DECYL-BETA-D-MALTOPYRANOSIDE(Non-covalent)
- 1 x CD: CADMIUM ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Hiser, C. et al., The K-path entrance in cytochrome c oxidase is defined by mutation of E101 and controlled by an adjacent ligand binding domain. Biochim. Biophys. Acta (2018)
- Release Date
- 2018-04-25
- Peptides
- Cytochrome c oxidase subunit 1: A
Cytochrome c oxidase subunit 2: B - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CB
D - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.40 Å
- Oligo State
- hetero-1-1-mer
- Ligands
- 2 x GLC- GLC: alpha-D-glucopyranose-(1-4)-alpha-D-glucopyranose(Non-covalent)
- 3 x TRD: TRIDECANE(Non-covalent)
- 1 x MG: MAGNESIUM ION(Non-covalent)
- 1 x CA: CALCIUM ION(Non-covalent)
- 3 x CU: COPPER (II) ION(Non-covalent)
- 2 x HEA: HEME-A(Non-covalent)
- 1 x DMU: DECYL-BETA-D-MALTOPYRANOSIDE(Non-covalent)
- 1 x CD: CADMIUM ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Hiser, C. et al., The K-path entrance in cytochrome c oxidase is defined by mutation of E101 and controlled by an adjacent ligand binding domain. Biochim. Biophys. Acta (2018)
- Release Date
- 2018-04-25
- Peptides
- Cytochrome c oxidase subunit 1: A
Cytochrome c oxidase subunit 2: B - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CB
D - Membrane
-
We predict this structure to be a membrane protein.